Disability, Intellectual
7
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury
Vaccinations and People With Disabilities
Program of Health Behaviour Against to Cancer (PHeBAC)
The Role of Family and Individual Factors in Going Through Adolescence - Perspective of a Healthy Child.
The Effectiveness of Baduajin in People With Intellectual Disability
Attitudes Towards Disability of Nursing and Physiotherapy Students
Importance of Multidimensional Assessments in Accompanying Schooling of Children With Mild to Moderate Intellectual Disability.